Finance
Novo, Hims & Hers engage in war of words after Wegovy deal falls apart
COPENHAGEN (Reuters) -Novo Nordisk said on Monday it would halt its collaboration with Hims & Hers H...
23rd June, 2025
healthcare
Latest articles
Finance
Novo Nordisk shares fall as obesity pipeline faces investor scrutiny
By Maggie Fick and Stine Jacobsen LONDON/COPENHAGEN (Reuters) -Shares in Novo Nordisk fell as much a...
23rd June, 2025
Headlines
Data on Novo Nordisk experimental weight-loss drug show mostly mild side effects
By Deena Beasley (Reuters) -Novo Nordisk on Sunday said full results from two late-stage trials of i...
22nd June, 2025
Headlines
Muscle-preserving drugs could generate over $30 billion in sales by 2035, TD Cowen says
By Bhanvi Satija (Reuters) -Treatments designed to help patients preserve muscle while losing weight...
20th June, 2025
Headlines
Trump aid cuts deal a blow to HIV prevention in Africa
By Robbie Corey-Boulet (Reuters) -Emmanuel Cherem, a 25-year-old gay man in Nigeria, tested positive...
20th June, 2025
Headlines
Israeli hospital had taken patients underground hours before missile hit
By Emily Rose BEERSHEBA, Israel (Reuters) -Shattered glass and piles of rubble littered the floors o...
19th June, 2025
Headlines
Lilly to appeal after UK agency opposes reimbursement for Alzheimer's drug
(Reuters) -Eli Lilly said on Thursday it would appeal against a UK agency's recommendation to not re...
18th June, 2025
Finance
Sixth Street-backed Caris Life valued at $7.7 billion in strong Nasdaq debut
(Reuters) -Caris Life Sciences' shares jumped nearly 29% in their New York debut on Wednesday, fetch...
18th June, 2025
Headlines
UK's Princess Kate, in recovery from cancer, to miss Royal Ascot
LONDON (Reuters) -Kate, Britain's Princess of Wales, will not be at Royal Ascot on Wednesday, with a...
18th June, 2025
Headlines
Sword Health valued at $4 billion in General Catalyst-led funding round
(Reuters) -Sword Health raised $40 million in a funding round led by General Catalyst, the company s...
17th June, 2025
Finance
AstraZeneca signs AI research deal with China's CSPC for chronic diseases
(Reuters) -AstraZeneca has signed a research agreement worth more than $5 billion with Chinese drugm...
13th June, 2025
Headlines
Novo Nordisk plans to start late-stage trials of obesity drug amycretin next year
(Reuters) -Novo Nordisk said on Thursday it plans to start late-stage trials of amycretin injection...
12th June, 2025